NEWTOWN, Pa., Jan. 28, 2014 /PRNewswire/ -- BioClinica®, Inc.,a global provider of clinical trial management services, announced today that Mundipharma Research, a dynamic pharmaceutical research and development company has selected BioClinica's OnPoint CTMS (Clinical Trial Management System). With this decision, Mundipharma Research plans to utilize OnPoint CTMS for various aspects of its clinical trial management activity.
Mundipharma Research selected OnPoint CTMS for its highly adaptive design that complements the company's approach to pharmaceutical development. OnPoint CTMS is a powerful end-to-end clinical trial management solution that brings improvements in control and efficiency of clinical trials. As a web-based CTMS, it gives sponsors the ability to view and manage real-time operational performance - wherever and whenever.
OnPoint's Office-Smart capabilities enhance Mundipharma Research's existing investment in Microsoft technologies by letting users access, update, and report on clinical trial data from within the familiar environment of Microsoft Office and SharePoint. Using SharePoint as a collaborative portal, OnPoint's web services integration with other trial management products provides an end-to-end trial management solution. This approach greatly enhances user adoption, and helps avoid the pitfalls of less adaptive CTMS products.
"We are very excited about Mundipharma Research's decision to utilize the OnPoint approach to clinical trial management," said Peter Benton, President of BioClinica's eClinical Solutions. "Mundipharma Research is known for being a dynamic organization wholly dedicated to the research and development of highly effective and innovative medications. This requires supporting technologies that empowers users and makes them more productive. OnPoint's customizable structure and robust reporting capabilities will accomplish this for Mundipharma Research while increasing collaboration and visibility."
BioClinica will be hosting its first BioClinica European User Conference on February 26th 2014 in Cologne, Germany. Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog and on twitter at http://twitter.com/bioclinica.
About Mundipharma Research
Mundipharma Research is a young, dynamic organisation wholly dedicated to the research and development of highly effective and innovative medications. Based in Europe (in Cambridge, England, and Limburg, Germany), we work on behalf of our independent associated companies and in collaboration with pharmaceutical companies to bring medications to both the European and the global market. Additional information about Mundipharma Research can be found at http://www.mundipharma-rd.eu
About BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services: medical imaging solutions including electronic transfer, management, and independent review; cardiovascular safety monitoring including automated ECG, Thorough QT studies, Holter monitoring, ambulatory blood pressure monitoring and pulse wave analysis; and eClinical solutions for electronic data capture, randomization, clinical trial management, and clinical supply chain forecasting and optimization. BioClinica offers unmatched scientific expertise with a team of respected medical researchers and board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. With more than 28 years of experience and over 3000 successful trials to date, BioClinica has supported the development of many new medicines through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide comprehensive cardiovascular safety, and eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com
SOURCE BioClinica, Inc.